Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPHEART.00571.2005PMID 15994854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.

  2003cited by this paper
• Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.

  2003cited by this paper
• Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling

  2003cited by this paper
• Folding and Function of the Troponin Tail Domain

  2003cited by this paper
• Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.

  2002cited by this paper
• Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

  2001cited by this paper
• Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T.

  2001cited by this paper
• Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

  2001cited by this paper
• Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force.

  2001influential reference
• Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T

  2001influential reference
• Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy*

  2001cited by this paper
• Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease

  2001influential reference
• Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

  2001cited by this paper
• Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.

  2001cited by this paper
• Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

  2000cited by this paper
• Different myofilament nearest-neighbor interactions have distinctive effects on contractile behavior.

  2000cited by this paper
• Altered Regulation of Cardiac Muscle Contraction by Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy*

  2000cited by this paper
• The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments.

  1999cited by this paper
• Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments.

  1998cited by this paper
• 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.

  1998cited by this paper
• Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

  1998cited by this paper
• A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.

  1998influential reference
• Sudden death due to troponin T mutations.

  1997cited by this paper
• Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy.

  1997cited by this paper
• Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy.

  1996cited by this paper
• Thin filament-mediated regulation of cardiac contraction.

  1996cited by this paper
• ATP utilization for calcium uptake and force production in skinned muscle fibres of Xenopus laevis.

  1995cited by this paper
• Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

  1995cited by this paper
• Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation.

  1995cited by this paper
• Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae.

  1995influential reference
• Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

  1994cited by this paper
• Equilibrium linkage analysis of cardiac thin filament assembly. Implications for the regulation of muscle contraction.

  1994cited by this paper
• Calcium and the heart: exchange at the tissue, cell, and organelle levels 1

  1992cited by this paper
• Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction.

  1988cited by this paper
• Interaction of rabbit skeletal muscle troponin T and F-actin at physiological ionic strength.

  1988cited by this paper
• Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

  1979cited by this paper
• Muscle structure and theories of contraction.

  1957cited by this paper

• Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy

  2025cites this paper
• Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial

  2025cites this paper
• Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy

  2024cites this paper
• Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation

  2024cites this paper
• Structural dynamics of the intrinsically disordered linker region of cardiac troponin T

  2024cites this paper
• The HCM – Linked Mutation Arg92Leu in TNNT2 Allosterically Alters the cTnC – cTnI Interface and Disrupts the PKA-mediated Regulation of Myofilament Relaxation

  2023cites this paper
• Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations

  2022cites this paper
• Beyond genomics—technological advances improving the molecular characterization and precision treatment of heart failure

  2020cites this paper
• Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging

  2020cites this paper
• Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy

  2020cites this paper
• Variant R94C in TNNT2‐Encoded Troponin T Predisposes to Pediatric Restrictive Cardiomyopathy and Sudden Death Through Impaired Thin Filament Relaxation Resulting in Myocardial Diastolic Dysfunction

  2020cites this paper
• Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.

  2020cites this paper
• Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.

  2019cites this paper
• Developmental increase in β-MHC enhances sarcomere length–dependent activation in the myocardium

  2019cites this paper
• Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy

  2019cites this paper
• Cardiac Disorders and Pathophysiology of Sarcomeric Proteins.

  2019cites this paper
• The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle

  2019cites this paper
• FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation

  2019cites this paper
• Extra energy for hearts with a genetic defect: ENERGY trial

  2019cites this paper
• Mechanistic complexity of contractile dysfunction in hypertrophic cardiomyopathy

  2018cites this paper
• Cardiomyopathy mutation (F88L) in troponin T abolishes length dependency of myofilament Ca2+ sensitivity

  2018cites this paper
• Biophysical Derangements in Genetic Cardiomyopathies.

  2018cites this paper
• Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models.

  2018cites this paper
• The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM

  2018cites this paper
• Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review

  2018cites this paper
• Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

  2018cites this paper
• UvA-DARE ( Digital Academic Repository ) Therapeutic targets in sickle cell disease

  2017cites this paper
• Disease Stage–Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy

  2017cites this paper
• Cardiomyopathy-related mutation (A30V) in mouse cardiac troponin T divergently alters the magnitude of stretch activation in α- and β-myosin heavy chain fibers.

  2017cites this paper
• Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.

  2017cites this paper
• Inherited Cardiomyopathies: From Genotype to Phenotype

  2017cites this paper
• Diseases of Cardiac Sarcomeres

  2017cites this paper
• Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

  2016cites this paper
• L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain

  2016cites this paper
• Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes.

  2016cites this paper
• In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models

  2016cites this paper
• Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy

  2016cites this paper
• Atomic resolution probe for allostery in the regulatory thin filament

  2016cites this paper
• Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation☆

  2016cites this paper
• Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants

  2016cites this paper
• Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.

  2015cites this paper
• The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.

  2015cites this paper
• Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.

  2014cites this paper
• A Drosophila melanogaster Model of Diastolic Dysfunction and Cardiomyopathy Based on Impaired Troponin-T Function

  2014cites this paper
• by thick filament mutations

  2014cites this paper
• Ablation of plasma membrane Ca(2+)-ATPase isoform 4 prevents development of hypertrophy in a model of hypertrophic cardiomyopathy.

  2014cites this paper
• Chapter 6 A novel HCM mutation in cardiac troponin T primarily alters cross-bridge kinetics and increases the energetic cost of tension generation in human cardiac tissue

  2014cites this paper
• Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?

  2014cites this paper
• Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.

  2014cites this paper
• Effects of pseudo-phosphorylated rat cardiac troponin T are differently modulated by α- and β-myosin heavy chain isoforms

  2014cites this paper
• The tropomyosin binding region of cardiac troponin T modulates crossbridge recruitment dynamics in rat cardiac muscle fibers.

  2013cites this paper
• HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.

  2013influential citation
• Cardiomyopathy-Related Mutations in Cardiac Troponin C, L29Q and G159D, Have Divergent Effects on Rat Cardiac Myofiber Contractile Dynamics

  2012cites this paper
• Correlation of Molecular and Functional Effects of Mutations in Cardiac Troponin T Linked to Familial Hypertrophic Cardiomyopathy

  2012cites this paper
• Consequences of Mutations in Genes Encoding Cardiac Troponin C, T and I – Molecular Insights

  2012cites this paper
• The N-terminal extension of cardiac troponin T stabilizes the blocked state of cardiac thin filament.

  2012cites this paper
• Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: a simulation study

  2012cites this paper
• Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform.

  2012cites this paper
• Alanine or aspartic acid substitutions at serine23/24 of cardiac troponin I decrease thin filament activation, with no effect on crossbridge detachment kinetics.

  2012cites this paper
• Abnormal heart rate regulation in murine hearts with familial hypertrophic cardiomyopathy-related cardiac troponin T mutations.

  2011cites this paper
• Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder

  2011cites this paper
• Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy.

  2011cites this paper
• Group of the National Heart, Lung, and Blood Institute Research Priorities in Hypertrophic Cardiomyopathy : Report of a Working

  2011cites this paper
• Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy

  2010cites this paper
• Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice*

  2010cites this paper
• Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?

  2010cites this paper
• Predicting Cardiomyopathic Phenotypes by Altering Ca2+ Affinity of Cardiac Troponin C*

  2010cites this paper
• Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.

  2010cites this paper
• Special Report Research Priorities in Hypertrophic Cardiomyopathy Report of a Working Group of the National Heart, Lung, and Blood Institute Genetic Cause

  2010cites this paper
• Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

  2010cites this paper
• Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.

  2009influential citation
• Nebulin Alters Cross-bridge Cycling Kinetics and Increases Thin Filament Activation

  2009cites this paper
• Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy

  2009cites this paper
• Challenging Current Paradigms Related to Cardiomyopathies: Are Changes in the Calcium Sensitivity of Myofilaments Containing Mutations Good Predictors of the Phenotypic Outcomes?

  2008cites this paper
• Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

  2008cites this paper
• A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin*

  2008cites this paper
• Challenging Current Paradigms Related to Cardiomyopathies

  2008cites this paper
• Sarcomeric proteins and inherited cardiomyopathies.

  2008cites this paper
• R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts.

  2007cites this paper
• Thin‐filament regulation of force redevelopment kinetics in rabbit skeletal muscle fibres

  2007cites this paper
• Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.

  2007cites this paper
• The genetics of hypertrophic cardiomyopathy: Teare redux

  2007cites this paper
• Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms

  2006influential citation
• Troponin T modulates sarcomere length-dependent recruitment of cross-bridges in cardiac muscle.

  2006cites this paper
• Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

  2005cites this paper
• The Functional Effect of Dilated Cardiomyopathy Mutation (r144w) in Mouse Cardiac Troponin T Is Differently Affected by ␣-and ␤-myosin Heavy Chain Isoforms

  year unknowncites this paper